Clinical Trial

Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Recruiting
View on ClinicalTrials.gov →
Summary
Commercial decalcified bone scaffolds were combined with autologous bone marrow mesenchymal stem cells to form tissue engineered bone in vitro to explore the effect of this tissue engineered bone in the clinical repair of long tubular bone defects in limbs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-04; most recent amendment 2025-12-28.
Status change: Not Yet Recruiting → Recruiting 2025-12-28
Trial Details
NCT Number NCT07066228
Lead Sponsor The First Affiliated Hospital of Xinxiang Medical College
Conditions Defective Composite Restorations, Bone Cysts, Bone Defect, Bone Nonunion
Enrollment 30 participants
Start Date 2025-08-07
Primary Completion 2027-01 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-02